Advancing Healthcare Solutions
.jpg)
Global Manufacturing Powerhouse
.jpg)
Committed to Top-Notch Quality
Our quality systems are built for consistency and traceability from incoming materials to finished product testing. We operate ISO-certified facilities and maintain controlled, documented processes supported by data-integrity controls aligned with 21 CFR Part 11 (where applicable).
Robust Intellectual Property Portfolio
Proprietary methods, specialised machines, and drug delivery techniques ensure precision and innovation in targeted and programmed drug delivery.
Envision Scientific manufactures drug-eluting stents (DES) and drug-coated balloons (DCB), delivering complex drugs through proprietary technologies.
Envision Scientific offer DES and DCB solutions for cardiovascular, peripheral, erectile dysfunction, and arterio-venous fistula treatments.
Press Articles
.jpg)
The primary results of the SirPAD trial were presented as a Late Breaking Clinical Presentation by Prof. Dr. Stefano Barco from the University Hospital Zurich on behalf of SirPAD Steering Committee members and investigators. The primary results of the SirPAD trial have been simultaneously published in the New England Journal of Medicine.
.jpg)
The SirPAD (Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated or uncoated balloon) randomised controlled trial is the world’s largest study evaluating the treatment of Peripheral Artery Disease (PAD) using the MagicTouch PTA Sirolimus Coated Balloon (Concept Medical Inc.) versus uncoated balloons and one of the largest device studies ever performed for PAD.